ARTELO BIOSCIENCES, INC. Contracts & Agreements
52 Contracts & Agreements
- Business Finance (27 contracts)
- Business Operations (6)
- Human Resources (5)
- Intellectual Property (10)
- Uncategorized (4)
- Description of Securities (Filed With SEC on March 25, 2024)
- DESCRIPTION OF THE REGISTRANTS SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 31, 2023)
- Purchase Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022 (Filed With SEC on May 16, 2022)
- Registration Rights Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022 (Filed With SEC on May 16, 2022)
- At Market Issuance Sales Agreement between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 9, 2021)
- Underwriting Agreement dated as of October 9, 2020, by and between Artelo Biosciences, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 14, 2020)
- Warrant Agency Agreement (Filed With SEC on October 14, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 6, 2020)
- Form of Underwriters Warrant (Filed With SEC on October 6, 2020)
- Form of Common Stock Warrant (Filed With SEC on October 6, 2020)
- Form of Lock-Up and Voting Agreement (Filed With SEC on October 6, 2020)
- Equity Distribution Agreement by and among the Company and Maxim Group LLC dated as of April 13, 2020 (Filed With SEC on April 15, 2020)
- Amended and Restated Employment Agreement by and between the Company and Gregory D. Gorgas dated August 30, 2019 (Filed With SEC on January 14, 2020)
- Amended and Restated Employment Agreement by and between the Company and Gregory D. Gorgas dated August 30, 2019 (Filed With SEC on November 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on June 20, 2019)
- Form of Public Warrant (Filed With SEC on June 20, 2019)
- Form of Underwriters Warrant (Filed With SEC on June 20, 2019)
- Form of Warrant Agency Agreement (Filed With SEC on June 20, 2019)
- First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute dated January 4, 2019 (Filed With SEC on April 15, 2019)
- First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute, dated as of January 4, 2019 (Filed With SEC on April 1, 2019)
- 2018 Equity Incentive Plan (Filed With SEC on September 27, 2018)
- Form of Stock Option Agreement2018 Equity Incentive Plan (Filed With SEC on September 27, 2018)
- Form of Series C Warrant (Filed With SEC on September 14, 2018)
- Form of Subscription Agreement (Filed With SEC on September 14, 2018)
- Form of Registration Rights Agreement (Filed With SEC on September 14, 2018)
- License Agreement with Stony Brook University, by and between the Company and Stony Brook University, dated January 18, 2018 (Filed With SEC on May 14, 2018)
- License Agreement with Stony Brook University, by and between the Company and Stony Brook University, dated January 18, 2018 (Filed With SEC on April 17, 2018)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on March 21, 2018)
- Exclusive License Agreement between The Research Foundation For The State University of New York and Artelo Biosciences, Inc. (Filed With SEC on March 21, 2018)
- Form of Series B Warrant (Filed With SEC on February 1, 2018)
- Form of Registration Rights Agreement (Filed With SEC on February 1, 2018)
- Form of Subscription Agreement dated January 26, 2018 (Filed With SEC on January 29, 2018)
- Material and Data Transfer, Option and License Agreement dated December 20, 2017 between the Company and NEOMED Institute (Filed With SEC on January 16, 2018)
- Material and Data Transfer, Option and License Agreement dated December 20, 2017 between the Company and NEOMED Institute (Filed With SEC on December 22, 2017)
- Form of Series A Warrant (Filed With SEC on October 3, 2017)
- Indemnification Agreement, by and between the Company and R. Martin Emanuele, dated September 20, 2017 (Filed With SEC on September 25, 2017)
- Indemnification Agreement, by and between the Company and Georgia Erbez, dated September 20, 2017 (Filed With SEC on September 25, 2017)
- Form of Series A Warrant (Filed With SEC on August 4, 2017)
- Form of Subscription Agreement (Filed With SEC on August 4, 2017)
- Form of Registration Rights Agreement (Filed With SEC on August 4, 2017)
- Amendment Dated August 1, 2017 to the Exclusive License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc (Filed With SEC on August 4, 2017)
- Exclusive Patent License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc (Filed With SEC on August 4, 2017)
- Indemnification Agreement Dated July 31, 2017 (Filed With SEC on August 4, 2017)
- Stock Purchase Agreement Dated August 1, 2017 (Filed With SEC on August 4, 2017)
- Exclusive License Agreement between Artelo Biosciences, Inc. and Analog Sciences, Inc (Filed With SEC on May 8, 2017)
- Form of Indemnification Agreement (Filed With SEC on May 8, 2017)
- Note Repayment Agreement between Artelo Biosciences, Inc. and Malibu Investments Limited (Filed With SEC on May 8, 2017)
- Stock Purchase Agreement dated May 4, 2017 (Filed With SEC on May 8, 2017)
- Consultancy Agreement between Reactive Medical, Inc. and Dr. Saoirse O'Sullivan, PhD dated March 22, 2017 (Filed With SEC on April 7, 2017)
- Employment Agreement between Reactive Medical, Inc. and Gregory D. Gorgas dated April 3, 2017 (Filed With SEC on April 7, 2017)
- Securities Purchase Agreement between Reactive Medical, Inc. and Gregory D. Gorgas dated April 3, 2017 (Filed With SEC on April 7, 2017)
- Senior Promissory Note, dated November 18, 2016 between our company and Malibu Investments Limited (Filed With SEC on November 18, 2016)
